Whole Genome Data

BAM files and phenotype data available to all investigators through completion of a Data Access Procedures process in the  St. Jude Cloud.

Public Access Whole Genome Data Tables

The table below provides characteristics for genome sequenced CCSS participants.

Characteristic CCSS Participants with Whole Exome Data (N=2641)
N %
Sex
Male 1240 47.5
Female 1401 52.5
Ancestry (based on genotype)
European 2114 78.8
Non-European 527 21.2
Primary Cancer Diagnosis
Acute lymphoblastic leumeia 452 35.1
Acute myeloid leukemia 77 2.3
Other leukemia 20 0.6
Astrocytoma 403 12.0
Medulloblastoma/PNET 167 5.0
Other CNS malignancy 104 3.1
Hodgkin lymphoma 311 9.2
Non-Hodgkin lymphoma 253 7.5
Kidney tumor 291 7.4
Neuroblastoma 256 7.6
Soft tissue sarcoma 138 4.1
Ewong sarcoma 90 2.7
Osteosarcoma 312 2.7
Other bone malignancy 20 0.6
Age at Cancer Diagnosis
0-4 yrs 922 39.9
5-9 yrs 626 25.9
10-14 yrs 654 20.8
15-21 yrs 439 13.4
Year of Cancer Diagnosis
1970 -1975 0  
1976-1981 0  
1982-1986 0  
1987-1991 974 37.0
1992-1995 856 33.4
1996-1999 811 29.6
Radiotherapy for Primary Cancer
Yes 1011 33.2
No 1535 63.3
Unknown* 95 3.5
Chemotherapy for Primary Cancer
Yes 2057 82.0
No 490 14.5
Unknown* 94 3.5

Percentages weighted to reflect modified sampling of all survivors in expansion cohort; WES, Whole Exome Sequencing; WGS, Whole Genome Sequencing.

*Participants did not provide consent for medical record.
#WES Data, Original Cohort, is a subset of the population with genotype data.